The Smart Investor
    Facebook Instagram
    Sunday, October 4
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»5 Small and Mid-Cap Singapore Stocks That Grew Their Revenue and Profits
    Dividend Stocks

    5 Small and Mid-Cap Singapore Stocks That Grew Their Revenue and Profits

    These five companies managed to increase both their revenue and profits even in a challenging macroeconomic environment.
    Royston Y.By Royston Y.August 27, 20255 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    AEM Holdings
    Image credit: aem.com.sg
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Most investors focus their attention on the blue-chip and REIT space as these sectors contain large, well-known businesses.

    While this approach is sound, these investors may also miss out on gems in the small and mid-cap space.

    Such companies may be smaller in size, but could also display healthy growth that will cause their share prices to appreciate over the long term.

    We shine the spotlight on five small and mid-sized companies that grew both their revenue and earnings during the recent earnings season.

    First Resources (SGX: EB5)

    First Resources is a leading palm oil producer that manages over 260,000 hectares of oil palm plantations across Indonesia.

    The group’s principal activities include the cultivation, harvesting, and sale of crude palm oil (CPO) and palm kernel (PK).

    For the first half of 2025 (1H 2025), sales jumped 47.4% year on year to US$673.9 million.

    This growth was supported by higher average selling prices and stronger sales volumes.

    Gross profit climbed 50.4% year on year to US$280.9 million, and underlying net profit soared 67.8% year on year to US$152 million.

    The CPO producer declared an interim dividend of S$0.045, 28.6% higher than the S$0.035 paid out a year ago.

    First Resources also enjoyed contributions from its acquisition of PT Austindo Nusantara Jaya (ANJ) in May 2025.

    Looking ahead, management expects seasonally higher output in 2H 2025.

    The integration of ANJ should also add to the group’s total volume, allowing it to report a better financial performance.

    Frencken (SGX: E28)

    Frencken is a technology solutions company that serves customers in the aerospace, analytical life sciences, healthcare, industrial, and semiconductor sectors.

    The group has 19 operating sites and employs more than 3,600 staff.

    For 1H 2025, revenue rose 15.7% year on year to S$431.4 million, while gross profit increased by 10.2% year on year to S$60.9 million.

    Net profit increased by 9.9% year on year to S$19.9 million.

    Free cash flow soared more than sixfold year on year from S$2.3 million to S$15 million.

    For 2H 2025, the group expects revenue to be stable compared with 1H 2025.

    Management intends to look for opportunities to execute its strategic initiatives, including the development of larger and improved manufacturing facilities in the US and Singapore.

    Just last week, Frencken broke ground on its new facility in Kaki Bukit Avenue 5 in Singapore.

    This larger and improved facility will help to expand and consolidate the group’s Mechatronics division.

    Construction will commence in the third quarter of 2025 (3Q 2025) and be completed by 1Q 2027, and the new facility will be 1.4 times the size of Frencken’s current combined operations.

    ISEC Healthcare (SGX: 40T)

    ISEC Healthcare provides a comprehensive suite of specialist medical eye care services and has ambulatory surgical centres located in Singapore, Malaysia, and Myanmar.

    For 1H 2025, revenue rose 7% year on year to S$37.8 million while gross profit improved by 8% year on year to S$17 million.

    The group saw net profit inch up 4% year on year to S$6.8 million.

    The healthcare company generated a positive free cash flow of S$2.7 million for 1H 2025.

    The group sees opportunities for growth in markets such as Vietnam and Myanmar, and will also strengthen its presence in its core markets of Singapore and Malaysia.

    ISEC Healthcare will also continue to pursue investment activities in line with its business strategies to help further grow its top and bottom lines.

    AEM Holdings (SGX: AWX)

    AEM Holdings provides comprehensive semiconductor and electronics test solutions.

    The group has manufacturing plants in countries such as Singapore, Malaysia, Indonesia, Vietnam, and several other countries.

    AEM reported a commendable set of earnings for 1H 2025 with revenue rising 9.6% year on year to S$190.3 million.

    Net profit soared 283% year on year to S$3.2 million.

    Part of this improvement was because of the pull-in of orders related to non-cancellable, long-dated purchase orders from one of its customers.

    The group also churned out a strong positive free cash flow of S$37.4 million, reversing the previous year’s negative free cash flow of S$1.8 million.

    AEM also announced the appointment of new CEO Samer Kabbani, who will succeed Amy Leong from 28 July 2025.

    Revenue for 2H 2025 is expected to be in the range of S$170 million to S$190 million, with a major customer expected to ramp up production in late 2025 or early 2026 for its next-generation AI accelerator.

    CSE Global (SGX: 558)

    CSE Global is a systems integrator providing electrification, communications, and automation solutions.

    The group has a presence in 15 countries with 61 offices and employs more than 2,000 staff globally.

    CSE Global reported a respectable set of earnings for 1H 2025 with revenue edging 2.8% higher year on year.

    Gross profit margin expanded slightly from 27.6% to 27.9%, and net profit increased by 8.5% year on year to S$16.3 million.

    The group, however, generated negative free cash flow for 1H 2025 and slashed its interim dividend from S$0.0125 to S$0.0114.

    CSE Global managed to secure S$366.7 million of new orders for 1H 2025, bringing its order book to S$573.8 million at the end of the half-year.

    This new 10-minute read could change how you invest this year. Inside: 

    5 SG dividend-paying blue chips that have quietly powered through past downturns, and could reward you handsomely in the next.

    Grab the free report now. It might be the most profitable thing you read today.

    Disclosure: Royston Yang does not own shares in any of the companies mentioned.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    The Smart Investor Smart Reads Pic 1

    Smart Reads of the Week: Singapore Stocks, REIT Opportunities, AI Growth, and Higher Dividends

    October 4, 2026
    coffee, notebook

    Smart Look At The Week Ahead: PepsiCo, Levi Strauss, Top Glove And Uniqlo

    October 3, 2026

    Top Stock Market Highlights of the Week: City Developments, Stoneweg Europe Stapled Trust, MAS, DFI Retail and Anthropic

    October 3, 2026
    Facebook Instagram LinkedIn Telegram YouTube TikTok
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.